Skip to main content

Displaying results 1 - 5 of 5
  • Content Type: Abstract

    Adverse drug events (ADEs) are a significant source of morbidity and mortality. The majority of post-marketing surveillance for ADEs is passive. Information regarding ADEs is reported to the medical community in peer-reviewed journals. However, in… read more
    … journals, our intuition is that letters to the editor may provide the earliest reports of ADEs. They often report … formal investigations and reports. Although these letters may contain useful and timely information, the challenge is … ehtj11115 ehtj11120 ehtj11024 ehtj11060 ehtj11110 26-50 ehtj11034 ehtj11198 ehtj11174 ehtj11048 ehtj11154 …
  • Content Type: Abstract

    Disease screening facilitates the reduction of disease prevalence in two ways: (1) by preventing transmission and (2) allowing for treatment of infected individuals. Hospitals choosing an optimal screening level must weigh the benefits of decreased… read more
    … Because of this interdependent relationship, one DU may have an incentive to "free-ride" off the screening … the disease prevalence declines. On the other hand, DUs may find it futile to invest in screening if they admit a … ehtj11115 ehtj11120 ehtj11024 ehtj11060 ehtj11110 26-50 ehtj11034 ehtj11198 ehtj11174 ehtj11048 ehtj11154 …
  • Content Type: Abstract

    Historically, patients with TB have often been diagnosed late or after death. This delay in diagnosis often occurs because TB is misdiagnosed as an alternative respiratory illness (RI), such as pneumonia . TB infected patients that are not… read more
    … are not correctly diagnosed when initial symptoms occur may spread infection to others in both healthcare settings … are not correctly diagnosed when initial symptoms occur may spread infection to others in both healthcare settings …
  • Content Type: Abstract

    Investigators have used the volume of internet search queries to model disease incidence, especially influenza and general consumer behavior [1]. Our group has used search volume to model interest in FDA safety alerts and adverse drug event… read more
    … and adverse drug event incidence. Thus, search volume may help provide near real time sur- veillance of drug use … and adverse drug event incidence. Thus, search volume may help provide near real time sur- veillance of drug use …
  • Content Type: Abstract

    Adverse drug events (ADEs) are a major cause of morbidity and mortality. However, post-marketing surveillance systems are passive and reporting is generally not mandated. Thus, many ADEs go unreported, and it is difficult to estimate and/or… read more
    … approval. Finally, the severity and frequency of ADEs may vary within a particular drug class, and search volume may provide additional information for guiding clinicians to … ehtj11115 ehtj11120 ehtj11024 ehtj11060 ehtj11110 26-50 ehtj11034 ehtj11198 ehtj11174 ehtj11048 ehtj11154 …